Creative Medical Technology Holdings, Inc. Common Stock vs. Kymera Therapeutics, Inc. Common Stock
CELZ
Creative Medical Technology Holdings, Inc. Common Stock
$1.22 -1.61%
VS KYMRKymera Therapeutics, Inc. Common Stock
$117.39 +2.60%
Kymera Therapeutics, Inc. Common Stock (KYMR) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| CELZ | KYMR | |
|---|---|---|
| Market Cap | $8.04 million | $9.76 billion |
| Revenue (TTM) | — | $105.00 million |
| Net Income (TTM) | — | $-299,601,000 |
KYMR leads on 1 of 1 size & scale factors.
Valuation
| CELZ | KYMR | |
|---|---|---|
| Price / Book | — | 6.47 |
| Price / Sales | — | 92.96 |
CELZ and KYMR split the valuation factors evenly.
Profitability
| CELZ | KYMR | |
|---|---|---|
| Net Margin | — | -285.34% |
| Return on Equity | — | -19.85% |
CELZ and KYMR split the profitability factors evenly.
Risk & Sentiment
| CELZ | KYMR | |
|---|---|---|
| Short Interest | 0.25% | 0.24% |
KYMR leads on 1 of 1 risk & sentiment factors.
Dig deeper: CELZ overview, CELZ financials, KYMR overview, KYMR financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.